116
Participants
Start Date
January 31, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
TQH3906 capsules
TQH3906 is an allosteric inhibitor targeting kinase.
The first hospital of Jilin University, Changchun
Meihekou Central Hospital, Meihekou
Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai
The First Affilliated Hospital of Bengbu Medical University, Bengbu
Tianjin People's Hospital, Tianjin
Xiangya Hospital of Central South University, Changsha
The First Affiliated Hospital Of University Of South China, Hengyang
Union Hosiptal, Tongji Medical College, Huazhong University of Science And Technolocy, Wuhan
Renmin Hospital of Wuhan University, Wuhan
Henan Provincial People's Hospital, Zhengzhou
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Luoyang First People's Hospital, Luoyang
First affiliated hospital of guangzhou medical university, Guangzhou
The First Affiliated Hospital of Kunming Medical University, Kunming
Gansu Wuwei Tumour Hospital, Wuwei
Shanxi Provincial People's Hospital, Taiyuan
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
INDUSTRY